Does Thymoma Plus Hypogammaglobulinemia Define Good Syndrome? A 30-Year Longitudinal Study of a Single Patient with Persistent B-Cell Preservation
International Journal of Molecular Sciences · 29.10.2026 · 27 (21) · 9726
DOI: 10.3390/ijms27219726 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.10.2026. Verfasst von Daniel Iguasnia Portilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department Service of Immunology and Genetics, Hospital Universitario San Pedro de Alcántara, 10003 Cáceres, Spain. Hauptthemen laut MEDLINE: Thymoma, Agammaglobulinemia, B-Lymphocytes, Thymus Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación.
Abstract (Originalsprache)
Good syndrome is commonly diagnosed when thymoma and hypogammaglobulinemia coexist, although universally accepted diagnostic criteria are lacking. Profound B-cell lymphopenia is one of its most consistent immunological features. We describe a woman followed for 30 years in our unit whose severe antibody deficiency preceded thymoma detection by 14 years. Circulating B cells were preserved before thymectomy and throughout 16 years of subsequent follow-up, with maintained class-switched memory B cells despite persistent antibody deficiency. Her clinical course was favorable under immunoglobulin replacement, without documented major opportunistic infections. T-cell differentiation abnormalities were present despite preserved absolute counts. These findings suggest that patients currently classified as Good syndrome may represent a more heterogeneous group than traditionally assumed. Although preserved B cells do not exclude Good syndrome under existing definitions, the present observation should be considered hypothesis-generating and supports further studies evaluating potential biological heterogeneity among patients diagnosed with Good syndrome. This case highlights the need for consensus diagnostic criteria that consider the temporal relationship between both conditions, B-cell numbers, and the accompanying immune abnormalities, rather than relying on the coexistence of thymoma and hypogammaglobulinemia alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department Service of Immunology and Genetics, Hospital Universitario San Pedro de Alcántara, 10003 Cáceres, Spain.
- Immunology Unit, Department of Physiology, Faculty of Veterinary Medicine, Universidad de Extremadura, 10003 Cáceres, Spain.
ORCID-Profile: Daniel Iguasnia Portilla, Isabel Castillo Castillo, Helena Fernández Cabrera, Hector Cordero, Luis Miguel Fernández Pereira
Förderung
- Agencia Estatal de Investigación
Zitieren
APA
Iguasnia Portilla, D., Castillo Castillo, I., Franco Figueroa, V., Fernández Cabrera, H., Romero Chala, S., Sobieschi, I., Cordero, H., & Fernández Pereira, L. M. (2026). Does Thymoma Plus Hypogammaglobulinemia Define Good Syndrome? A 30-Year Longitudinal Study of a Single Patient with Persistent B-Cell Preservation. International Journal of Molecular Sciences, 27(21), 9726. https://doi.org/10.3390/ijms27219726
Vancouver
Iguasnia Portilla D, Castillo Castillo I, Franco Figueroa V, Fernández Cabrera H, Romero Chala S, Sobieschi I, et al. Does Thymoma Plus Hypogammaglobulinemia Define Good Syndrome? A 30-Year Longitudinal Study of a Single Patient with Persistent B-Cell Preservation. International Journal of Molecular Sciences. 2026;27(21):9726. doi:10.3390/ijms27219726
BibTeX
@article{IguasniaPortilla2026,
author = {Iguasnia Portilla, Daniel and Castillo Castillo, Isabel and Franco Figueroa, Valeria and Fernández Cabrera, Helena and Romero Chala, Silvia and Sobieschi, Irina and Cordero, Hector and Fernández Pereira, Luis Miguel},
title = {Does Thymoma Plus Hypogammaglobulinemia Define Good Syndrome? A 30-Year Longitudinal Study of a Single Patient with Persistent B-Cell Preservation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9726},
doi = {10.3390/ijms27219726}
}
EUVIMED